查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829648

2025年全球連續性腎臟替代療法市場報告

Continuous Renal Replacement Therapy Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，連續性腎臟替代療法 (CRRT) 市場快速擴張，市場規模從 2024 年的 15.7 億美元成長至 2025 年的 17.3 億美元，複合年成長率為 10.5%。預測期內的成長歸因於對先進 CRRT 設備的需求不斷成長、急性腎損傷發病率上升、醫療應用日益增多、合併症患病率高以及持續的研發投入。

預計未來幾年，連續性腎臟替代療法 (CRRT) 市場規模將快速成長，到 2029 年將達到 25.5 億美元，複合年成長率為 10.2%。預測期內的成長歸因於慢性腎臟病率的上升、糖尿病患病率的上升、重症監護病房 (ICU) 入院人數的增加、醫療基礎設施投資的增加以及兒科護理應用的不斷擴展。預測期內的主要趨勢包括快速發展、新技術的推出、技術進步、產品創新以及技術先進的 CRRT 產品。

持續性腎臟替代療法 (CRRT) 是一種透析方法，透過分階段、持續的血液濾過來調節液體、電解質和廢物水平，適用於血流動力學不穩定的急性腎損傷 (AKI)重症患者。 CRRT 在管理液體超負荷方面發揮重要作用，尤其適用於心血管系統不穩定、無法耐受間歇性血液血液透析機快速清除液體的重症患者。

連續性腎臟替代療法 (CRRT) 市場的關鍵產品是系統和耗材。連續性腎臟替代療法 (CRRT) 系統是用於治療急性腎重症患者的專用醫療設備。它們採用不同的模式提供各種腎臟和非腎臟治療，例如慢速連續超過濾(SCUF)、連續性靜脈-血液透析機(CVVHD) 和連續性靜脈-靜脈血液濾過 (CVVHDF)。這些療法可在各種環境中（包括醫院、門診護理中心和居家照護機構）用於成人、兒童和新生兒。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司（The Business Research Company）新報告系列的一部分，該系列提供持續性腎臟替代療法（CRT）的市場統計數據，例如持續性腎臟替代療法（CRT）行業的全球市場規模、各地區市場佔有率、競爭對手的市場佔有率、詳細的持續性腎臟替代療法（CRT）細分市場、市場趨勢和商機，以及您在持續性腎臟（CRT）細分市場、市場趨勢和商機，以及您在持續性腎臟（CRT）細分市場、市場趨勢和商機，以及您在持續性腎臟（CRT）細分市場、市場趨勢和商機，以及您在持續性腎臟（CRT）細分市場、市場趨勢和商機，以及您在持續性腎臟（CRT）細分市場、市場趨勢和商機，以及您在持續性腎臟（CRT）細分市場、市場趨勢和商機，以及您在持續性腎臟（CRT）細分市場、市場趨勢和商機，以及您在持續性腎臟（CRT）細分市場、市場趨勢和商機，以及您在持續性腎臟（CRT）本持續性腎臟替代療法市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切資訊的完整觀點。

我們預測未來五年該市場將成長10.2%，較我們先前對該市場的預測略有下降0.8%。下降的主要原因是美國與其他國家之間的關稅影響。這可能會透過對來自義大利和中國等關鍵地區的高通量血液過濾器和無菌透析液袋徵收關稅直接影響美國，從而導致重症加護能力下降，並增加治療急性腎損傷的成本。由於互惠關稅以及不斷升級的貿易摩擦和限制對全球經濟和貿易的負面影響，這種影響也可能更為廣泛。

慢性腎臟病(CKD) 盛行率的不斷上升預計將在未來幾年推動連續性腎臟替代療法 (CRRT) 市場的擴張。 CKD 是一種長期疾病，其特徵是腎功能逐漸下降，損害器官過濾血液中廢物的能力。 CKD 病例的增加主要是由於生活方式的改變、人口老化以及糖尿病和高血壓盛行率的上升等因素。連續性腎臟替代療法 (CRRT) 通常用於治療 CKD 的急性發作和併發症，幫助調節體液平衡並持續清除代謝廢物。例如，2024 年 5 月，美國疾病管制與預防中心 (CDC) 報告稱，美國有超過 3,550 萬成年人（約七分之一）患有 CKD。令人驚訝的是，其中近 90% 的人並不知道自己的病情，這凸顯了美國在早期發現和宣導活動方面存在巨大差距。

連續性腎臟替代療法 (CRRT) 市場的主要企業專注於為透析患者開發先進的腎臟治療解決方案，旨在改善治療效果、提高患者預後並減少與傳統透析相關的併發症。與傳統透析不同，這種療法是持續進行的（通常每天 24 小時）並且對身體溫和，特別適合患有急性腎損傷或嚴重疾病的患者。例如，2023 年 1 月，美國提供急診和外科服務的醫療機構佩科尼克灣醫療中心 (PBMC) 為透析患者推出了新的腎臟治療選擇。該療法旨在為健康狀況使標準透析難以忍受的患者提供更舒適的透析體驗。 CRRT 比傳統透析的給藥更緩慢，可減輕重症患者的壓力。

2024年8月，以生產醫療產品而聞名的美國醫療保健公司百特國際（Baxter International）以38億美元收購了凱雷集團（The Carlyle Group）。透過此次收購，凱雷集團增強了其在腎臟護理領域的投資組合，並致力於滿足慢性腎臟病病患者對創新透析產品和服務日益成長的需求。凱雷集團是一家專注於持續性腎臟替代療法（CRT）的美國投資公司。

連續性腎臟替代療法市場的主要參與者包括美敦力公司、費森尤斯醫療股份公司、旭化成株式會社、東麗株式會社、百特國際公司、B. Braun Melsungen AG、泰爾Terumo Corporation TechnologiesS. Srl、寧波天一醫療器材有限公司、Cytosorbents Corporation、Kawasumi Laboratories Inc.、Medica SpA、Infomed SA、Medites Pharma Spol.SRO、日機裝株式會社、Kawasumi Laboratories、Medica SpA、Infomed SA、Medites Pharm Spol.Ltd.、Medcomp Systems Ltd. 等。

2024年，北美是連續性腎臟替代療法市場規模最大的地區。預計亞太地區將成為預測期內成長最快的地區。連續性腎臟替代療法市場報告涵蓋亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。

連續性腎臟替代療法市場報告涵蓋的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、英國、美國、義大利和西班牙。

連續性腎臟替代療法 (CRRT) 市場由提供急性血液透析機、水分離和液體管理等服務的營業單位所獲得的收益構成。市場價值包括服務提供者銷售或包含在其服務產品中的相關產品的價值。連續性腎臟替代療法市場還包括透析導管、透析液、止血劑和氣道系統的銷售。該市場的價值為“出廠價”，即產品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的產品價值。該市場中的產品價值還包括產品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球連續性腎臟替代療法：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球連續性腎臟替代治療市場：成長率分析
  • 全球連續性腎臟替代療法市場表現：規模與成長，2019-2024
  • 全球連續性腎臟替代療法市場預測：規模與成長，2024-2029，2034
  • 全球連續性腎臟替代療法：總目標市場（TAM）

第6章 市場細分

  • 全球連續性腎臟替代治療市場（依產品、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 系統
  • 耗材
  • 全球連續性腎臟替代療法市場（按治療類型、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 腎
  • 非腎臟
  • 全球連續性腎臟替代治療市場（按模式、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 慢速連續超過濾（SCUF）
  • 持續性靜脈-靜脈血液濾過（CVVH）
  • 持續性血液透析機（CVVHD）
  • 持續性靜脈-靜脈血液透析濾過（CVVHDF）
  • 全球連續性腎臟替代治療市場（按年齡層、績效及預測）2019-2024 年、2024-2029 年、2034 年
  • 成人
  • 小兒科或新生兒
  • 全球連續性腎臟替代治療市場（按最終用戶、績效和預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 門診治療
  • 居家護理
  • 全球連續性腎臟替代療法市場：按系統、類型、表現和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 血液過濾器
  • CRRT機
  • 血管組
  • 全球連續性腎臟替代治療市場：按耗材（類型）細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 透析液
  • 補充品
  • 導管
  • 血統集

第7章 區域和國家分析

  • 全球連續性腎臟替代治療市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球連續性腎臟替代治療市場：國家、績效及預測（2019-2024、2024-2029、2034）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 連續性腎臟替代療法市場：競爭格局
  • 連續性腎臟替代治療市場：公司簡介
    • Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
    • Fresenius Medical Care AG & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
    • Asahi Kasei Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Toray Industries Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • B. Braun Melsungen AG
  • Terumo Corporation
  • Nipro Corporation
  • NxStage Medical Inc.
  • Hillrom Holdings Inc.
  • Gambro AB
  • JMS Co. Ltd.
  • Quanta Dialysis Technologies Ltd.
  • Bellco Srl
  • Ningbo Tianyi Medical Devices Co. Ltd.
  • Cytosorbents Corporation
  • Kawasumi Laboratories Inc.
  • Medica SpA
  • Infomed SA
  • Medites Pharma Spol. SRO

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年持續性腎臟替代療法市場：提供新機會的國家
  • 2029年持續性腎臟替代治療市場：細分市場帶來新機會
  • 2029年連續性腎臟替代療法市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r29883u

Continuous renal replacement therapy (CRRT) is a form of dialysis that provides gradual, ongoing blood filtration to help regulate levels of fluids, electrolytes, and waste products in critically ill patients with acute kidney injury (AKI) who are hemodynamically unstable. It plays a crucial role in managing fluid overload in critically ill patients, particularly those who cannot tolerate rapid fluid removal through intermittent hemodialysis due to cardiovascular instability.

The primary products in the continuous renal replacement therapy market are systems and consumables. A continuous renal replacement therapy (CRRT) system is a specialized medical device utilized in treating critically ill patients with AKI or other renal conditions. It offers various renal and non-renal therapies using different modalities such as slow continuous ultrafiltration (SCUF), continuous venovenous hemofiltration (CVVH), continuous venovenous hemodialysis (CVVHD), and continuous venovenous hemodiafiltration (CVVHDF). These therapies are administered to adults, pediatrics, and neonates in various settings including hospitals, ambulatory care centers, and homecare setups.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The continuous renal replacement therapy market research report is one of a series of new reports from The Business Research Company that provides continuous renal replacement therapy market statistics, including continuous renal replacement therapy industry global market size, regional shares, competitors with a continuous renal replacement therapy market share, detailed continuous renal replacement therapy market segments, market trends and opportunities, and any further data you may need to thrive in the continuous renal replacement therapy industry. This continuous renal replacement therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The continuous renal replacement therapy market size has grown rapidly in recent years. It will grow from $1.57 billion in 2024 to $1.73 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to increased demand for advanced CRRT devices, an increase in the prevalence of incidence of acute kidney injury, a rise in the number of medical applications, a high prevalence of co-morbidities, and continuous research and development.

The continuous renal replacement therapy market size is expected to see rapid growth in the next few years. It will grow to $2.55 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to increasing incidences of chronic kidney diseases, rising prevalence of diabetes, a growing number of ICU admissions, rising investments in healthcare infrastructure, and expanding applications in pediatric care. Major trends in the forecast period include rapid advancements, launches of new technologies, technological advancements, product innovation, and technologically advanced CRRT products.

The forecast of 10.2% growth over the next five years reflects a modest reduction of 0.8% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on high-flux hemofilters and sterile dialysis solution bags, sourced from key regions such as Italy and China, which could lead to reduced critical care capacity and increased costs for acute kidney injury treatment.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing prevalence of chronic kidney disease (CKD) is expected to drive the expansion of the continuous renal replacement therapy (CRRT) market in the future. CKD is a long-term condition in which kidney function gradually declines, impairing the organ's ability to filter waste from the blood. This increase in CKD cases is largely attributed to factors such as lifestyle changes, an aging population, and higher rates of diabetes and hypertension. Continuous renal replacement therapy is commonly used to manage acute exacerbations or complications of CKD, helping to regulate fluid balance and remove metabolic waste continuously. For example, in May 2024, the Centers for Disease Control and Prevention (CDC) reported that more than 35.5 million adults in the United States-about 1 in 7-are affected by CKD. Alarmingly, nearly 90% of these individuals are unaware of their condition, highlighting the significant gap in early detection and awareness efforts in the U.S.

Leading companies in the continuous renal replacement therapy (CRRT) market are concentrating on developing advanced renal therapy solutions for dialysis patients, aiming to improve treatment effectiveness, enhance patient outcomes, and reduce complications linked to conventional dialysis methods. Unlike traditional dialysis, this therapy runs continuously-usually over a 24-hour period-and is gentler on the body, making it particularly suitable for patients with acute kidney injuries or severe medical conditions. For example, in January 2023, Peconic Bay Medical Center (PBMC), a U.S.-based healthcare facility offering emergency and surgical services, introduced a new renal therapy option for dialysis patients. This therapy is designed to offer greater comfort to patients who may not tolerate standard dialysis due to their health conditions. CRRT is administered more gradually than traditional dialysis, which helps reduce stress on critically ill patients.

In August 2024, Baxter International Inc., a U.S.-based healthcare company known for producing medical products, acquired The Carlyle Group Inc. for $3.8 billion. This acquisition allows Carlyle Group to strengthen its portfolio in renal care, positioning itself to capitalize on the increasing demand for innovative dialysis products and services for patients with chronic kidney disease. The Carlyle Group Inc. is a U.S.-based investment firm with a focus on continuous renal replacement therapy.

Major companies operating in the continuous renal replacement therapy market are Medtronic Plc, Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Corporation, Toray Industries Inc., Baxter International Inc., B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, NxStage Medical Inc., Hillrom Holdings Inc., Gambro AB, JMS Co. Ltd., Quanta Dialysis Technologies Ltd., Bellco S.r.l., Ningbo Tianyi Medical Devices Co. Ltd., Cytosorbents Corporation, Kawasumi Laboratories Inc., Medica S.p.A., Infomed SA, Medites Pharma Spol. S.R.O, Nikkiso Co. Ltd., Anjue Medical Equipment Co. Ltd., Medcomp Systems Ltd.

North America was the largest region in the continuous renal replacement therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the continuous renal replacement therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the continuous renal replacement therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The continuous renal replacement therapy (CRRT) market consists of revenues earned by entities by providing services such as acute hemodialysis, aquapheresis, and fluid management. The market value includes the value of related goods sold by the service provider or included within the service offering. The continuous renal replacement therapy market also includes sales of dialysis catheters, dialysates, hemostatic agents, and airway clearance systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Continuous Renal Replacement Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on continuous renal replacement therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for continuous renal replacement therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The continuous renal replacement therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: System; Consumables
  • 2) By Therapy: Renal; Non-Renal
  • 3) By Modality: Slow Continuous Ultra-Filtration (SCUF); Continuous Venovenous Hemofiltration (CVVH); Continuous Venovenous Hemodialysis (CVVHD); Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 4) By Age Group: Adults; Pediatrics Or Neonates
  • 5) By End-Users: Hospitals; Ambulatory Care; Homecare
  • Subsegments:
  • 1) By System: Hemofilters; CRRT Machines; Blood Tubing Sets
  • 2) By Consumables: Dialysate Solutions; Replacement Fluids; Catheters; Bloodline Sets
  • Companies Mentioned: Medtronic Plc; Fresenius Medical Care AG & Co. KGaA; Asahi Kasei Corporation; Toray Industries Inc.; Baxter International Inc.; B. Braun Melsungen AG; Terumo Corporation; Nipro Corporation; NxStage Medical Inc.; Hillrom Holdings Inc.; Gambro AB; JMS Co. Ltd.; Quanta Dialysis Technologies Ltd.; Bellco S.r.l.; Ningbo Tianyi Medical Devices Co. Ltd.; Cytosorbents Corporation; Kawasumi Laboratories Inc.; Medica S.p.A.; Infomed SA; Medites Pharma Spol. S.R.O; Nikkiso Co. Ltd.; Anjue Medical Equipment Co. Ltd.; Medcomp Systems Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Continuous Renal Replacement Therapy Market Characteristics

3. Continuous Renal Replacement Therapy Market Trends And Strategies

4. Continuous Renal Replacement Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Continuous Renal Replacement Therapy Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Continuous Renal Replacement Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Continuous Renal Replacement Therapy Market Growth Rate Analysis
  • 5.4. Global Continuous Renal Replacement Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Continuous Renal Replacement Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Continuous Renal Replacement Therapy Total Addressable Market (TAM)

6. Continuous Renal Replacement Therapy Market Segmentation

  • 6.1. Global Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • System
  • Consumables
  • 6.2. Global Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Renal
  • Non-Renal
  • 6.3. Global Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Slow Continuous Ultra-Filtration (SCUF)
  • Continuous Venovenous Hemofiltration (CVVH)
  • Continuous Venovenous Hemodialysis (CVVHD)
  • Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 6.4. Global Continuous Renal Replacement Therapy Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Adults
  • Pediatrics Or Neonates
  • 6.5. Global Continuous Renal Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Care
  • Homecare
  • 6.6. Global Continuous Renal Replacement Therapy Market, Sub-Segmentation Of System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hemofilters
  • CRRT Machines
  • Blood Tubing Sets
  • 6.7. Global Continuous Renal Replacement Therapy Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Dialysate Solutions
  • Replacement Fluids
  • Catheters
  • Bloodline Sets

7. Continuous Renal Replacement Therapy Market Regional And Country Analysis

  • 7.1. Global Continuous Renal Replacement Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Continuous Renal Replacement Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Continuous Renal Replacement Therapy Market

  • 8.1. Asia-Pacific Continuous Renal Replacement Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Continuous Renal Replacement Therapy Market

  • 9.1. China Continuous Renal Replacement Therapy Market Overview
  • 9.2. China Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Continuous Renal Replacement Therapy Market

  • 10.1. India Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Continuous Renal Replacement Therapy Market

  • 11.1. Japan Continuous Renal Replacement Therapy Market Overview
  • 11.2. Japan Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Continuous Renal Replacement Therapy Market

  • 12.1. Australia Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Continuous Renal Replacement Therapy Market

  • 13.1. Indonesia Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Continuous Renal Replacement Therapy Market

  • 14.1. South Korea Continuous Renal Replacement Therapy Market Overview
  • 14.2. South Korea Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Continuous Renal Replacement Therapy Market

  • 15.1. Western Europe Continuous Renal Replacement Therapy Market Overview
  • 15.2. Western Europe Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Continuous Renal Replacement Therapy Market

  • 16.1. UK Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Continuous Renal Replacement Therapy Market

  • 17.1. Germany Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Continuous Renal Replacement Therapy Market

  • 18.1. France Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Continuous Renal Replacement Therapy Market

  • 19.1. Italy Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Continuous Renal Replacement Therapy Market

  • 20.1. Spain Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Continuous Renal Replacement Therapy Market

  • 21.1. Eastern Europe Continuous Renal Replacement Therapy Market Overview
  • 21.2. Eastern Europe Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Continuous Renal Replacement Therapy Market

  • 22.1. Russia Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Continuous Renal Replacement Therapy Market

  • 23.1. North America Continuous Renal Replacement Therapy Market Overview
  • 23.2. North America Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Continuous Renal Replacement Therapy Market

  • 24.1. USA Continuous Renal Replacement Therapy Market Overview
  • 24.2. USA Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Continuous Renal Replacement Therapy Market

  • 25.1. Canada Continuous Renal Replacement Therapy Market Overview
  • 25.2. Canada Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Continuous Renal Replacement Therapy Market

  • 26.1. South America Continuous Renal Replacement Therapy Market Overview
  • 26.2. South America Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Continuous Renal Replacement Therapy Market

  • 27.1. Brazil Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Continuous Renal Replacement Therapy Market

  • 28.1. Middle East Continuous Renal Replacement Therapy Market Overview
  • 28.2. Middle East Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Continuous Renal Replacement Therapy Market

  • 29.1. Africa Continuous Renal Replacement Therapy Market Overview
  • 29.2. Africa Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Continuous Renal Replacement Therapy Market Competitive Landscape And Company Profiles

  • 30.1. Continuous Renal Replacement Therapy Market Competitive Landscape
  • 30.2. Continuous Renal Replacement Therapy Market Company Profiles
    • 30.2.1. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Fresenius Medical Care AG & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Asahi Kasei Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Toray Industries Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Continuous Renal Replacement Therapy Market Other Major And Innovative Companies

  • 31.1. B. Braun Melsungen AG
  • 31.2. Terumo Corporation
  • 31.3. Nipro Corporation
  • 31.4. NxStage Medical Inc.
  • 31.5. Hillrom Holdings Inc.
  • 31.6. Gambro AB
  • 31.7. JMS Co. Ltd.
  • 31.8. Quanta Dialysis Technologies Ltd.
  • 31.9. Bellco S.r.l.
  • 31.10. Ningbo Tianyi Medical Devices Co. Ltd.
  • 31.11. Cytosorbents Corporation
  • 31.12. Kawasumi Laboratories Inc.
  • 31.13. Medica S.p.A.
  • 31.14. Infomed SA
  • 31.15. Medites Pharma Spol. S.R.O

32. Global Continuous Renal Replacement Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Continuous Renal Replacement Therapy Market

34. Recent Developments In The Continuous Renal Replacement Therapy Market

35. Continuous Renal Replacement Therapy Market High Potential Countries, Segments and Strategies

  • 35.1 Continuous Renal Replacement Therapy Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Continuous Renal Replacement Therapy Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Continuous Renal Replacement Therapy Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer